North of England private equity firm invests £15m in industrial diseases ABS


Jackson: investment will allow firm to accelerate growth

NorthEdge Capital, a private equity firm focused on the North of England, has announced an investment of £15m into Roberts Jackson, the Cheshire-based industrial disease alternative business structure.

The firm, which has grown from two to 200 people in five years, acts for claimants who have developed diseases as a result of their employer`s negligence.

Karen Jackson, CEO of Roberts Jackson, said: “This is a very exciting time for the business and we are delighted to welcome NorthEdge Capital on board as an investor.

“The introduction of alternative business structures through the Legal Services Act 2007 has created interesting opportunities for firms like ours.

“The investment from NorthEdge will allow us to accelerate the growth of the business, capitalise on new opportunities within the market and hopefully provide many more clients with the very best advice.

“Ultimately as lawyers we are here to serve our clients to the best of our ability and this investment will enable us to build upon our existing platform within the legal services sector.”

Grant Berry, managing partner at NorthEdge Capital, director Jon Pickering, and investment manager Phil Frame led the deal. Mr Berry and Mr Pickering join the board as non-executive directors while Mr Frame joins as an observer.

Mr Pickering commented: “Roberts Jackson is a hugely successful business and we look forward to working alongside Karen, Oliver and the management team as the business continues to grow and develop.

“We are in no doubt that the coming months will see Roberts Jackson further increase its market share and continue to deliver unmatched specialist expertise.”

The deal is the seventh transaction completed by NorthEdge Capital from its maiden fund, which closed at £225million in March 2013, and represents over £100million of investment into the Northern business community during the last 18 months.

The private equity firm focuses exclusively on Northern-based companies seeking equity investments to support MBOs, development capital and equity release.

It targets the lower mid-market with investment in businesses with an enterprise value of £10million to £100million, with equity investments from £5million to £45million in any one deal.

 

Tags:




Leave a Comment

By clicking Submit you consent to Legal Futures storing your personal data and confirm you have read our Privacy Policy and section 5 of our Terms & Conditions which deals with user-generated content. All comments will be moderated before posting.

Required fields are marked *
Email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Reports

Our latest special report, produced in association with Temple Legal Protection, looks at the role of after-the-event (ATE) insurance in commercial litigation post-LASPO. We are at a time when insurers, solicitors, clients and litigation funders work ever more closely to create funding packages that work for all of them, with conditional fee and even damages-based agreements now part of many law firms’ armoury.

Blog

16 October 2019

The new SRA accounts rules – a checklist for compliant software

There are a number of changes to the accounts rules from 25 November, which law firm managers and compliance officers will need to take into account in order for their firms not to be in breach.

Read More

Loading animation